Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease

Clinical trial NCT01421719 · COMPLETED

Trial details

NCT number: NCT01421719
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson's Disease Neurogenic Bladder Urinary Incontinence Clostridium Botulinum Toxin Adverse Reaction

Start date: 2009-02-01
Primary completion: 2011-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.